When lung cancer is caught in its early stages, long-term survival rates can reach 80% and higher, according to a new large-scale, 20-year international study presented at this year's RSNA meeting.

A new partnership between Sirona Medical and RevealDX could streamline the process of AI integration into the clinical practice of lung nodule assessments. 

The Israeli vendor Nanox says it has a vision for the future of healthcare. It seeks to address health disparities and access challenges with a new business model and innovative package of technologies. Hurdles loom, but opportunities abound. 

Personalized breast cancer screening programs could help women better understand their personal cancer risks and guide providers in recommending mammographic assessments based on these risks. 

Brian Lindman, MD, medical director of the Structural Heart and Valve Center, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program to screen with echo to find more AS patients. 

For women with dense breasts, it can be particularly challenging to differentiate between actual and perceived breast cancer risks.  

Experts are calling for strategies to improve follow-up adherence among individuals who have positive lung cancer screenings after a new analysis revealed low rates of compliance. 

Bhvita Jani, research manager, Signify Research, explains key trends and technology advances in the computed tomography (CT) market.